Apella Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$379K Sell
4,347
-28
-0.6% -$2.53K ﹤0.01% 571
2026
Q2
$416K Buy
4,375
+428
+11% +$37.4K 0.01% 508
2026
Q1
$339K Buy
+3,947
New +$352K 0.01% 526

Other funds holding CL

Apella Capital's CL Position: Q3 2026 in Review

Apella Capital reduced its Colgate-Palmolive (CL) stake by 0.64% in Q3 2026, selling an estimated $2.53K and leaving 4,347 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #571.

Apella Capital first reported a position in CL in Q1 2026 and has held it in 3 quarters since. The position peaked at $416K in Q2 2026. 494 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Apella Capital held 4,347 shares of Colgate-Palmolive worth $379K as of Q3 2026.
  • Apella Capital sold 28 Colgate-Palmolive shares in Q3 2026, an estimated $2.53K.
  • Colgate-Palmolive made up ﹤0.01% of Apella Capital's portfolio in Q3 2026, its #571 holding.
  • Apella Capital first reported a position in Colgate-Palmolive in Q1 2026 and has held it in 3 quarters since.
  • Apella Capital's Colgate-Palmolive position peaked at $416K in Q2 2026.
  • 494 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.